SECTORS TODAY
Tech XLK -4.89%
Financials XLF -0.76%
Healthcare XLV +0.45%
Energy XLE +1.91%
Industrials XLI -1.60%
Cons. Disc. XLY -0.71%
Cons. Staples XLP +1.41%
Utilities XLU +0.67%
Materials XLB +0.40%
Real Estate XLRE +0.26%
Comm. Svcs XLC -1.29%

Earnings release · TJX

TJX REPORTS Q2 FY27 RESULTS; ABOVE-PLAN COMP SALES GROWTH OF 4%; PRETAX PROFIT MARGIN AND DILUTED EPS BOTH WELL ABOVE PLAN; INCREASES FULL YEAR FY27 PRETAX PROFIT MARGIN AND EPS GUIDANCE

Tjx Companies Inc. · Filed · SEC Form 8-K, Item 2.02

Tjx Companies Inc. company page Original on SEC.gov ↗

Revenue $29.5 billion +7% vs a year ago
EPS $1.36 +24% vs a year ago
Guidance raisedoutlook statement
Automated extract. The items below were picked out of the company's press release by software and may be wrong or incomplete. Please read the original before relying on any figure. Not investment advice.

Why it matters

Revenue grew 7% year on year to $29.5 billion, and EPS increased 24% to $1.36. Sales and earnings both ahead of a year ago is generally the cleaner kind of result. The company lifted its guidance, which is usually read as management's view of coming periods improving.

Written automatically by Stocknote's note engine from the figures on this page and the company's previous release. Every number in this note is checked against those figures. Not investment advice.

What the company states

Revenue

$29.5 billion +7% vs a year ago

…For the first half of Fiscal 2027, net sales were $29.5 billion, an increase of 7% versus the first half of Fiscal 2026.…
EPS

$1.36 +24% vs a year ago

…Q2 diluted earnings per share of $1.36, up 24% versus last year and well above the Company’s plan…
Guidance

Guidance raised

…-PLAN COMP SALES GROWTH OF 4%; PRETAX PROFIT MARGIN AND DILUTED EPS BOTH WELL ABOVE PLAN; INCREASES FULL YEAR FY27 PRETAX PROFIT MARGIN AND EPS GUIDANCE.…

Read the original press release on SEC.gov ↗ Filing index ↗

Trend: last 1 reports

All releases →

Revenue growth (YoY)

EPS growth (YoY)

Disclaimer: This page is generated automatically from public SEC filings for information only. Stocknote does not edit the company's release and does not guarantee the accuracy of the extracted items. Read the full disclaimer here.

Get new research in your inbox

Forensic equity research on US stocks. No spam, unsubscribe anytime.